The improvement in
technology, surgical techniques and immunosuppressive drugs, Kidney
transplantation has became the preferred treatment for chronic kidney disease
for many people. A transplant may offer the best chance of returning to a more
normal life. Kidney transplantation has increasingly become a pivotal
intervention for thousands of patients suffering from fatal end stage kidney
disease (ESRD).
North America is one
of the biggest kidney transplant market in the world. The overall number of
Kidney Transplant done in North America (United States, Mexico and Canada) was
more than 20 Thousand in 2014. United States is the leader in kidney transplant
market in North America. Canada has the least number of kidney transplant done
in comparison to United States and Mexico. Despite its high medical cost today
United States Kidney Transplant Market is a Billion US$ industry.
“Kidney Transplant
Market, Numbers & Forecast for United States, Mexico & Canada”
explores a comprehensive assessment of the fast–evolving, high growth Kidney
Transplant Market. This 53 page report with 33 Figures & 1 Table provides
the number of kidney transplant, as well as market and market shares of Kidney
Transplant Market. The report entails major kidney transplant
(Immunosuppressant) drug sales analysis. This report also covers drivers and
challenges of North America (United States, Mexico and Canada) market.
Purchase a
copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=400060 .
All the 3 Countries studied in the report are as
follows
- United States
- Canada
- Mexico
All the 6 Kidney Transplant Immunosuppressant) drugs
studied in the report are as follows
- CellCept (MycophenolateMofetil)
- Prograf (Tacrolimus)
- Rapamune (Sirolimus)
- Myfortic (Mycophenolic Acid)
- Neoral / Sandimmune (Cyclosporine)
- Zortress / Certican (Everolimus)
View
Complete Report @ http://www.marketreportsonline.com/400060.html .
Table of Contents
1. Executive Summary
2. North America (United States, Mexico & Canada)
– Number of Kidney Transplant & Forecast
3. North America (United States, Mexico & Canada)
– Kidney Transplant Market & Forecast
4. North America (United States, Mexico & Canada)
– Number of Kidney Transplant, Market & Drugs Market Share & Forecast
4.1 North America (United States, Mexico & Canada) – Number of Kidney Transplant Share & Forecast
4.2 North America (United States, Mexico & Canada) – Kidney Transplant Market Share & Forecast
4.3 Number of Kidney Transplant Centers in United States, Canada & Mexico
4.1 North America (United States, Mexico & Canada) – Number of Kidney Transplant Share & Forecast
4.2 North America (United States, Mexico & Canada) – Kidney Transplant Market Share & Forecast
4.3 Number of Kidney Transplant Centers in United States, Canada & Mexico
5. United States
5.1 United States – Number of Kidney Transplant & Forecast
5.2 United States – Kidney Transplant Market & Forecast
5.1 United States – Number of Kidney Transplant & Forecast
5.2 United States – Kidney Transplant Market & Forecast
6. Mexico
6.1 Mexico – Number of Kidney Transplant & Forecast
6.2 Mexico – Kidney Transplant Market & Forecast
6.1 Mexico – Number of Kidney Transplant & Forecast
6.2 Mexico – Kidney Transplant Market & Forecast
7. Canada
7.1 Canada – Number of Kidney Transplant & Forecast
7.2 Canada – Kidney Transplant Market & Forecast
7.1 Canada – Number of Kidney Transplant & Forecast
7.2 Canada – Kidney Transplant Market & Forecast
8. Kidney Transplantation (Immunosuppressant) Drug
Sales Analysis
8.1 CellCept (MycophenolateMofetil) Drugs Sales & Forecast
8.2 Prograf (Tacrolimus) Drug Sales & Forecast
8.3 Rapamune (Sirolimus) Drug Sales & Forecast
8.4 Myfortic (Mycophenolic Acid) Drug Sales & Forecast
8.5 Neoral / Sandimmune (Cyclosporine) Drug Sales & Forecast
8.6 Zortress / Certican (Everolimus) Drug Sales & Forecast
8.1 CellCept (MycophenolateMofetil) Drugs Sales & Forecast
8.2 Prograf (Tacrolimus) Drug Sales & Forecast
8.3 Rapamune (Sirolimus) Drug Sales & Forecast
8.4 Myfortic (Mycophenolic Acid) Drug Sales & Forecast
8.5 Neoral / Sandimmune (Cyclosporine) Drug Sales & Forecast
8.6 Zortress / Certican (Everolimus) Drug Sales & Forecast
9. Growth Drivers in the Kidney Transplant Market
9.1 Frequency of Living Related Kidney Donation Has Increased
9.2 Patients Who Have Kidney Transplants Usually Live Longer Than Patients Receiving Dialysis
9.1 Frequency of Living Related Kidney Donation Has Increased
9.2 Patients Who Have Kidney Transplants Usually Live Longer Than Patients Receiving Dialysis
10. Challenges in the Kidney Transplant Market
10.1 Kidney Transplant Waitlist is Long
10.1 Kidney Transplant Waitlist is Long
TOC of This Report @ http://www.marketreportsonline.com/400060-toc.html .
List of Figures
Figure 2 1: North America (United States, Mexico &
Canada) – Number of Kidney Transplant (Number), 2006 – 2014
Figure 2 2: North America (United States, Mexico & Canada) – Forecast for Number of Kidney Transplant (Number), 2015 – 2020
Figure 3 1: North America (United States, Mexico & Canada) – Kidney Transplant Market (Million US$), 2006 – 2014
Figure 3 2: North America (United States, Mexico & Canada) – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 4 1: North America (United States, Mexico & Canada) – Number of Kidney Transplant Share (Percent), 2006 – 2014
Figure 4 2: North America (United States, Mexico & Canada) – Forecast for Number of Kidney Transplant Share (Percent), 2015 – 2020
Figure 4 3: North America (United States, Mexico & Canada) – Kidney Transplant Market Share (Percent), 2006 – 2014
Figure 4 4: North America (United States, Mexico & Canada) – Kidney Transplant Market Share (Percent), 2015 – 2020
Figure 5 1: United States – Number of Kidney Transplant (Number), 2004 – 2014
Figure 5 2: United States – Forecast for Number of Kidney Transplant (Number), 2015 – 2020
Figure 5 3: United States – Kidney Transplant Market (Million US$), 2004 – 2014
Figure 5 4: United States – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 6 1: Mexico – Number of Kidney Transplant (Number), 2006 – 2014
Figure 6 2: Mexico – Forecast for number of Kidney Transplant (Number), 2015 – 2020
Figure 6 3: Mexico – Kidney Transplant Market (Million US$), 2006 – 2014
Figure 6 4: Mexico – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 7 1: Canada – Number of Kidney Transplant (Number), 2004 – 2014
Figure 7 2: Canada – Forecast for number of Kidney Transplant (Number), 2015 – 2020
Figure 7 3: Canada – Kidney Transplant Market (Million US$), 2004 – 2014
Figure 7 4: Canada – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 9 1: Worldwide – CellCept Drug Sales (Million US$), 2005 – 2014
Figure 9 2: Worldwide – Forecast for CellCept Drug Sales (Million US$), 2015 – 2020
Figure 9 3: Worldwide – Prograf Drug Sales (Million US$), 2004 – 2014
Figure 9 4: Worldwide – Forecast for Prograf Drug Sales (Million US$), 2015 – 2020
Figure 9 5: Worldwide – Rapamune Drug Sales (Million US$), 2009 – 2014
Figure 9 6: Worldwide – Forecast for Rapamune Drug Sales (Million US$), 2015 – 2020
Figure 9 7: Worldwide – Myfortic Drug Sales (Million US$), 2008 – 2014
Figure 9 8: Worldwide – Forecast for Myfortic Drug Sales (Million US$), 2015 – 2020
Figure 9 9: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2007 – 2014
Figure 9 10: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2015 – 2020
Figure 9 11: Worldwide – Zortress/Certican Drug Sales (Million US$), 2008 – 2014
Figure 9 12: Worldwide – Forecast for Zortress / Certican Drug Sales (Million US$), 2015 – 2020
Figure 10 1: United States – Number of Kidney Living Donor (Number), 2000 – 2013
Figure 2 2: North America (United States, Mexico & Canada) – Forecast for Number of Kidney Transplant (Number), 2015 – 2020
Figure 3 1: North America (United States, Mexico & Canada) – Kidney Transplant Market (Million US$), 2006 – 2014
Figure 3 2: North America (United States, Mexico & Canada) – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 4 1: North America (United States, Mexico & Canada) – Number of Kidney Transplant Share (Percent), 2006 – 2014
Figure 4 2: North America (United States, Mexico & Canada) – Forecast for Number of Kidney Transplant Share (Percent), 2015 – 2020
Figure 4 3: North America (United States, Mexico & Canada) – Kidney Transplant Market Share (Percent), 2006 – 2014
Figure 4 4: North America (United States, Mexico & Canada) – Kidney Transplant Market Share (Percent), 2015 – 2020
Figure 5 1: United States – Number of Kidney Transplant (Number), 2004 – 2014
Figure 5 2: United States – Forecast for Number of Kidney Transplant (Number), 2015 – 2020
Figure 5 3: United States – Kidney Transplant Market (Million US$), 2004 – 2014
Figure 5 4: United States – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 6 1: Mexico – Number of Kidney Transplant (Number), 2006 – 2014
Figure 6 2: Mexico – Forecast for number of Kidney Transplant (Number), 2015 – 2020
Figure 6 3: Mexico – Kidney Transplant Market (Million US$), 2006 – 2014
Figure 6 4: Mexico – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 7 1: Canada – Number of Kidney Transplant (Number), 2004 – 2014
Figure 7 2: Canada – Forecast for number of Kidney Transplant (Number), 2015 – 2020
Figure 7 3: Canada – Kidney Transplant Market (Million US$), 2004 – 2014
Figure 7 4: Canada – Forecast for Kidney Transplant Market (Million US$), 2015 – 2020
Figure 9 1: Worldwide – CellCept Drug Sales (Million US$), 2005 – 2014
Figure 9 2: Worldwide – Forecast for CellCept Drug Sales (Million US$), 2015 – 2020
Figure 9 3: Worldwide – Prograf Drug Sales (Million US$), 2004 – 2014
Figure 9 4: Worldwide – Forecast for Prograf Drug Sales (Million US$), 2015 – 2020
Figure 9 5: Worldwide – Rapamune Drug Sales (Million US$), 2009 – 2014
Figure 9 6: Worldwide – Forecast for Rapamune Drug Sales (Million US$), 2015 – 2020
Figure 9 7: Worldwide – Myfortic Drug Sales (Million US$), 2008 – 2014
Figure 9 8: Worldwide – Forecast for Myfortic Drug Sales (Million US$), 2015 – 2020
Figure 9 9: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2007 – 2014
Figure 9 10: Worldwide – Neoral / Sandimmune Drug Sales (Million US$), 2015 – 2020
Figure 9 11: Worldwide – Zortress/Certican Drug Sales (Million US$), 2008 – 2014
Figure 9 12: Worldwide – Forecast for Zortress / Certican Drug Sales (Million US$), 2015 – 2020
Figure 10 1: United States – Number of Kidney Living Donor (Number), 2000 – 2013
Browse More Reports of Pharmaceuticals
@ http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html .
Website: http://www.marketreportsonline.com/
Press Releases: http://www.prnewswire.com/news/market+reports+online
